Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma.
Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA.
Hao
H
Xie
David M
DM
Peereboom
D015746:Abdominal Pain / Q000209:etiology; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D003106:Colon / Q000473:pathology*; D003112:Colonic Pseudo-Obstruction / Q000139:chemically induced* / Q000175:diagnosis* / Q000628:therapy; D019299:Decompression, Surgical; D004108:Dilatation, Pathologic / Q000175:diagnosis / Q000628:therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects*; D009388:Neostigmine / Q000627:therapeutic use*; D010277:Parasympathomimetics / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D010277:Parasympathomimetics; D009388:Neostigmine; D008727:Methotrexate